P374: THROMBOTIC EVENTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: EXPERIENCE OF ITALIAN AIEOP CENTERS (2009-2017)

Ngā tūemi rite

• Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol
  mā: Carmelo Rizzari, me ētahi atu.
  I whakaputaina: (2023-06-01)
• Results in pediatric T‐ALL patients treated in trial AIEOP‐BFM ALL 2009: Prognostic factors in the context of modern risk‐adapted therapy
  mā: Gunnar Cario, me ētahi atu.
  I whakaputaina: (2025-09-01)
• Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated <i>E. coli</i> asparaginase in children with acute lymphocytic leukemia
  mā: Alaeddin Khalil, me ētahi atu.
  I whakaputaina: (2020-12-01)
• P374: THROMBOTIC EVENTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: EXPERIENCE OF ITALIAN AIEOP CENTERS (2009-2017)
  mā: Raffaele Mattera, me ētahi atu.
  I whakaputaina: (2023-08-01)
• Hypersensitivity Reactions to Native E. coli L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction
  mā: Anja Möricke, me ētahi atu.
  I whakaputaina: (2023-06-01)